News

ResMed Inc. hit a new 52-week high, surpassing its previous peak of $293.08, which the company achieved on August 4th.
Milestones underscore Resmed's leadership and commitment to delivering life-changing health technology that people loveSAN DIEGO, Aug. 21, 2025nasal cradle mask won two prestigious Red Dot Awards: Pro ...
Shares of ResMed Inc. RMD slid 1.03% to $284.72 Thursday, on what proved to be an all-around mixed trading session for the ...
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in th ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has provided an announcement. Resmed Inc has filed a notice ...
SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2025.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) just unveiled an announcement. ResMed Inc has announced an ...
Citi analyst Mathieu Chevrier maintained a Buy rating on CSL today and set a price target of A$300.00. The company’s shares closed today at $139.97. Take advantage of TipRanks Premium at 50% off!
SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal fourth-quarter earnings of $379.7 million.
SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal fourth-quarter earnings of $379.7 million.
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics OperationsHer appointment brings over 30 years of strategic, commercial, and operational expertise in the ...